The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...